1177 related articles for article (PubMed ID: 7624777)
1. Weight-reducing effects of the plasma protein encoded by the obese gene.
Halaas JL; Gajiwala KS; Maffei M; Cohen SL; Chait BT; Rabinowitz D; Lallone RL; Burley SK; Friedman JM
Science; 1995 Jul; 269(5223):543-6. PubMed ID: 7624777
[TBL] [Abstract][Full Text] [Related]
2. Effects of the obese gene product on body weight regulation in ob/ob mice.
Pelleymounter MA; Cullen MJ; Baker MB; Hecht R; Winters D; Boone T; Collins F
Science; 1995 Jul; 269(5223):540-3. PubMed ID: 7624776
[TBL] [Abstract][Full Text] [Related]
3. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.
Campfield LA; Smith FJ; Guisez Y; Devos R; Burn P
Science; 1995 Jul; 269(5223):546-9. PubMed ID: 7624778
[TBL] [Abstract][Full Text] [Related]
4. Decreased food intake does not completely account for adiposity reduction after ob protein infusion.
Levin N; Nelson C; Gurney A; Vandlen R; de Sauvage F
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1726-30. PubMed ID: 8643697
[TBL] [Abstract][Full Text] [Related]
5. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
6. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS
Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
[TBL] [Abstract][Full Text] [Related]
7. Leptin: the weight-reducing plasma protein encoded by the obese gene.
Wolf G
Nutr Rev; 1996 Mar; 54(3):91-3. PubMed ID: 8935220
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.
Erickson JC; Hollopeter G; Palmiter RD
Science; 1996 Dec; 274(5293):1704-7. PubMed ID: 8939859
[TBL] [Abstract][Full Text] [Related]
9. Dose-related steady states of fat loss in long-term leptin-treated ob/ob mice: leptin resistance or desensitization versus counterregulatory signaling.
Eiden S; Simon E; Schmidt I
J Comp Physiol B; 2005 Oct; 175(7):487-97. PubMed ID: 16088390
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice.
Lalonde J; Samson P; Poulin S; Deshaies Y; Richard D
Physiol Behav; 2004 Jan; 80(4):415-20. PubMed ID: 14741225
[TBL] [Abstract][Full Text] [Related]
11. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
12. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.
Weigle DS; Bukowski TR; Foster DC; Holderman S; Kramer JM; Lasser G; Lofton-Day CE; Prunkard DE; Raymond C; Kuijper JL
J Clin Invest; 1995 Oct; 96(4):2065-70. PubMed ID: 7560100
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice.
Hwa JJ; Ghibaudi L; Compton D; Fawzi AB; Strader CD
Horm Metab Res; 1996 Dec; 28(12):659-63. PubMed ID: 9013737
[TBL] [Abstract][Full Text] [Related]
14. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
Scislowski PW; Tozzo E; Zhang Y; Phaneuf S; Prevelige R; Cincotta AH
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):425-31. PubMed ID: 10340822
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation of the leptin gene in the pathogenesis of obesity.
Ioffe E; Moon B; Connolly E; Friedman JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11852-7. PubMed ID: 9751754
[TBL] [Abstract][Full Text] [Related]
16. Induction of uncoupling protein expression in brown and white adipose tissue by leptin.
Commins SP; Watson PM; Padgett MA; Dudley A; Argyropoulos G; Gettys TW
Endocrinology; 1999 Jan; 140(1):292-300. PubMed ID: 9886838
[TBL] [Abstract][Full Text] [Related]
17. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
Dokas J; Chadt A; Joost HG; Al-Hasani H
Int J Obes (Lond); 2016 Aug; 40(8):1242-9. PubMed ID: 27089993
[TBL] [Abstract][Full Text] [Related]
18. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.
Igel M; Becker W; Herberg L; Joost HG
Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.
Attele AS; Zhou YP; Xie JT; Wu JA; Zhang L; Dey L; Pugh W; Rue PA; Polonsky KS; Yuan CS
Diabetes; 2002 Jun; 51(6):1851-8. PubMed ID: 12031973
[TBL] [Abstract][Full Text] [Related]
20. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice.
Hwa JJ; Fawzi AB; Graziano MP; Ghibaudi L; Williams P; Van Heek M; Davis H; Rudinski M; Sybertz E; Strader CD
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1204-9. PubMed ID: 9140021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
